Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Onderzoekers ontdekken nieuwe therapeutische doelwitten voor MS
apr 2025 | Multipele Sclerose